نتایج جستجو برای: neuraminidase enzyme

تعداد نتایج: 246210  

Journal: :The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2010
Elsa Hansen Troy Day Julien Arino Jianhong Wu Seyed M Moghadas

BACKGROUND The use of neuraminidase inhibitors (oseltamivir and zanamivir) for the treatment of ill individuals has been an important intervention during the 2009 H1N1 pandemic. However, the emergence and spread of drug resistance remains a major concern and, therefore, optimizing antiviral strategies is crucial to retain the long-term effectiveness of these pharmaceutical interventions. METH...

Journal: :Indian journal of experimental biology 1999
P Swain K C Verma J M Kataria S K Mohanty

Two mouse monoclonal antibodies (MAbs), viz. 2B7 and 2 D10 raised against haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus (NDV) were used to identify several other field isolates and vaccine strains of NDV. These MAbs reacted specifically with all the NDV strains/isolates in Dot-ELISA whereas, only MAb 2D10 reacted with all the NDV strains/isolates in agar gel precipitation...

2017
Sudhir Venkatesan Puja R. Myles Jo Leonardi-Bee Stella G. Muthuri Malak Al Masri Nick Andrews Carlos Bantar Gal Dubnov-Raz Patrick Gérardin Evelyn S. C. Koay Tze Ping Loh Ziad Memish Elizabeth Miller Maria E. Oliva Barbara A. Rath Brunhilde Schweiger Julian W. Tang Dat Tran Tjasa Vidmar Pauline A. Waight Jonathan S. Nguyen-Van-Tam

Background While evidence exists to support the effectiveness of neuraminidase inhibitors (NAIs) in reducing mortality when given to hospitalized patients with A(H1N1)pdm09 virus infection, the impact of outpatient treatment on hospitalization has not been clearly established. We investigated the impact of outpatient NAI treatment on subsequent hospitalization in patients with A(H1N1)pdm09 viru...

Journal: :Acta biochimica Polonica 2014
Aneta Nitsch-Osuch Lidia Bernadeta Brydak

Neuraminidase inhibitors (NAIs) are antiviral drugs for treatment and prophylaxis of influenza. By blocking the activity of the enzyme neuraminidase, NAIs prevent new viral particles from being released. The increasing use of NAIs brings into focus the risk of drug resistance arising to the class. There are three levels of antiviral resistance according to the way that resistance can be detecte...

Journal: :Molecules 2016
Xian-Ying Yang Ai-Lin Liu Shu-Jing Liu Xiao-Wei Xu Lin-Fang Huang

OBJECTIVE To screen for influenza virus neuraminidase inhibition and to provide a reference for the clinical treatment of influenza using traditional Chinese medicines (TCM). In this study, 421 crude extracts (solubilized with petroleum ether, ethanol, ethyl acetate, and aqueous solvents) were obtained from 113 TCM. The medicine extracts were then reacted with oseltamivir, using 2'-(4-methylumb...

Journal: :Protein science : a publication of the Protein Society 2004
Pascal Bonnet Richard A Bryce

We report molecular dynamics calculations of neuraminidase in complex with an inhibitor, 4-amino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid (N-DANA), with subsequent free energy analysis of binding by using a combined molecular mechanics/continuum solvent model approach. A dynamical model of the complex containing an ionized Glu119 amino acid residue is found to be consistent with experiment...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011
Daisuke Tamura Norio Sugaya Makoto Ozawa Ryo Takano Masataka Ichikawa Masahiko Yamazaki Chiharu Kawakami Hideaki Shimizu Ritei Uehara Maki Kiso Eiryo Kawakami Keiko Mitamura Yoshihiro Kawaoka

BACKGROUND Although influenza virus resistance to the neuraminidase inhibitor zanamivir is reported less frequently than is resistance to the neuraminidase inhibitor oseltamivir in clinical settings, it is unknown whether this difference is due to the limited use of zanamivir or to an inherent property of the drug. We therefore compared the prevalence of drug-resistant viruses and virus sheddin...

Journal: :Blood 1986
R E Gallagher D A Giangiulio C S Chang C J Glover R L Felsted

The total sialic acid concent of retinoic acid (RA)-resistant or 6-thioguanine (6TG)-resistant HL-60 cells was more than tenfold lower and of dimethylsulfoxide (DMSO)-resistant HL-60 cells was approximately twofold lower than that of parental, wild-type (wt) HL-60 cells. Neuraminidase-inaccessible, ie residual cell-associated sialic acid after neuraminidase treatment, was four- to twelvefold lo...

2017
Laura E Liao Szymon Kowal Daniel A Cardenas Catherine A A Beauchemin

Mathematical models (MMs) have been used to study the kinetics of influenza A virus infections under antiviral therapy, and to characterize the efficacy of antivirals such as neuraminidase inhibitors (NAIs). NAIs prevent viral neuraminidase from cleaving sialic acid receptors that bind virus progeny to the surface of infected cells, thereby inhibiting their release, suppressing infection spread...

Journal: :Glycobiology 2013
M Motiur Rahman Satoshi Kitao Daisuke Tsuji Kaori Suzuki Jun-Ichi Sakamoto Koji Matsuoka Fumiko Matsuzawa Sei-Ichi Aikawa Kohji Itoh

Human sialidase 2 (NEU2) is a cytoplasmic sialidase that degrades sialylglycoconjugates, including glycoproteins and gangliosides, via hydrolysis of terminal sialic acids to produce asialo-type molecules. Here, we first report the inhibitory effects of a series of synthetic sialyldendrimers comprising three types [Dumbbell(1)6-S-Neu5Ac(6), Fan(0)3-S-Neu5Ac(3) and Ball(0)4-S-NeuAc(4)] toward rec...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید